Eli Lilly and Co at Wolfe Research Healthcare Conference (Virtual) Transcript
Great. Okay. Well, thanks for joining us. I'm Tim Anderson, the large-cap pharma and biotech analyst at Wolfe Research. And for the next 30 or 35 minutes, we'll be talking with Josh Smiley, who is Senior Vice President and the CFO for Eli Lilly.
Since joining the company in 1995, he's held executive positions across finance and sales and marketing. His experience includes leading U.S. sales and marketing efforts to payers such as managed care organizations and Medicare and Medicaid. We're just going to jump straight into Q&A given the limited time.
Questions & Answers
High-level questions first, just touching on health care reform. I know what the industry wants to see happen, which is things like a lower out-of-pocket spending and that sort of thing. But my question is really trying to understand what's likely to happen as the new administration takes over? So in that sense, asking you to kind of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
